← Evidence map

ReviewCancers2025

Aberrant Splicing as a Mechanism for Resistance to Cancer Therapies.

Duygu Duzgun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40282556